Quote | Agenus Inc. (NASDAQ:AGEN)
|Last Trade Date Time:||12/01/2023 03:00:00 am|
News | Agenus Inc. (NASDAQ:AGEN)
2023-11-30 15:11:10 ET More on Agenus, GSK, etc. Getting_Ahead_of_Respiratory_Diseases_Slides GSK plc (GSK) Getting Ahead of Respiratory Diseases Event with GSK Management Conference (Transcript) GSK plc (GSK) Presents at Redburn Atlantic CEO Conference (Transcript) ...
2023-11-07 06:50:04 ET More on Agenus Agenus: Getting The Tough Decisions Right With Catalysts Ahead Agenus: Immuno-Oncology Advancements Amidst Fiscal Pressures Agenus to cut 25% staff as lead program takes priority Seeking Alpha’s Quant Rating on Age...
Message Board Posts | Agenus Inc. (NASDAQ:AGEN)
|whytestocks: $AGEN News Article - Agenus Selected for Late-Breaking Oral Presentation at ESMO-GI||whytestocks||investorshangout||05/03/2023 6:35:51 PM|
|shalbyj: TheStreetReports: AI Biotech Stocks to Watch 2023: $IPA, $ONTX, $AGEN, $PBIO https://www.ma||shalbyj||investorshangout||04/25/2023 1:37:15 PM|
|whytestocks: $AGEN News Article - Agenus Receives Fast Track Designation for Botensilimab and Balsti||whytestocks||investorshangout||04/17/2023 12:00:59 PM|
|whytestocks: $AGEN News Article - Agenus' Botensilimab in Combination with Balstilimab Shows 33% Dur||whytestocks||investorshangout||03/27/2023 3:10:50 PM|
|whytestocks: $AGEN News Article - Best Penny Stocks To Buy Now: 3 To Watch Before Next Week||whytestocks||investorshangout||03/15/2023 8:20:47 PM|
News, Short Squeeze, Breakout and More Instantly...
Agenus Inc. Company Name:
AGEN Stock Symbol:
Agenus Inc. Website:
Conference Call on Tuesday, November 7, 2023, at 9:00 a.m. ET Agenus Inc. (“Agenus”) (Nasdaq: AGEN), a leader in discovering and developing novel immunological agents to treat various cancers, today announced results for the third quarter 2023. Agenus executives will host ...
Weyco Group Inc. (WEYS) is expected to report for Q1 2024 Gladstone Land Corporation (LAND) is expected to report $0.16 for Q3 2023 PlayAGS Inc. (AGS) is expected to report $0.01 for Q3 2023 Ardmore Shipping Corporation (ASC) is expected to report $0.43 for Q3 2023 Sage Therapeuti...
Agenus Inc. (AGEN) is expected to report $-0.19 for Q3 2023